Why the Rhinomed (ASX:RNO) share price is rocketing 90% higher today

This medical device company is benefiting from COVID testing…

Sonic Healthcare share price represented by man receiveing nasal swab from medical professional

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Rhinomed Ltd (ASX: RNO) share price is rocketing higher on Wednesday.

In morning trade, the medical device company's shares are up a massive 90% to a 52-week high of 38 cents.

This means the Rhinomed share price is now up approximately 125% since the start of the year.

Why is the Rhinomed share price rocketing higher?

The catalyst for the rise in the Rhinomed share price on Wednesday has been the announcement of a major purchase order from the government.

According to the release, the company has received purchase orders and begun supplying NSW Health Pathology with an initial one million Rhinoswabs. This is part of NSW Health Pathology's program to support testing capability.

The company has commenced deliveries, with these initial orders being fulfilled over the coming weeks. It notes that the revenue associated with the initial order represents between approximately 25% and 35% of its unaudited FY 2021 revenues of $3.9 million.

What is Rhinoswab?

The company highlights that its Rhinoswab nasal swab technology improves the sample collection process.

Rhinoswab is reportedly substantially more comfortable and easier to use than the standard nasal swab, captures a larger sample, can accelerate the sample collection process, and significantly reduce queues and waiting times.

The technology works with existing PCR pathology workflows and equipment and has equivalent cost and quality to the US and European standard of care nasopharyngeal swabs.

In order to respond to increasing demand both at home and abroad, Rhinomed is now scaling up its manufacturing facilities.

Rhinomed's CEO, Michael Johnson, said: "We are thrilled to receive this support for this Australian innovation. The Rhinoswab can make a meaningful impact on the SARS-CoV-2 testing process and enable more people to be tested quickly and easily. With approximately 2 billion SARS-CoV-2 tests having been carried out globally over the last 18 months (close to 26 million in Australia alone), there is a major opportunity for Rhinoswab to radically improve the testing process, clinical outcomes and user experience."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today
Industrials Shares

Up 39% in a year, is there more growth to come for this ASX 200 share?

IML Equity Analyst Josh Freiman shares his views on a major ASX 200 industrial stock.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Catapult, Flight Centre, Nufarm, and Xero shares are storming higher today

These shares are having a strong session on Thursday. But why? Let's find out.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 made it three-for-three losses in a row this Wednesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Brickworks, James Hardie, Megaport, and OFX shares are charging higher today

These shares are having a good time on hump day. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors endured another day of selling this Tuesday.

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Guess which ASX 300 tech stock is already up 64% in November!

The ASX 300 tech stock is surging higher this month. But why?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ANZ, Block, Neuren, and Pilbara Minerals shares are pushing higher today

These shares are having a solid session on Tuesday. But why? Let's find out.

Read more »